BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
58 hedge funds and large institutions have $14.1M invested in BRAINSTORM CELL THERAPUTC in 2023 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
31% less capital invested
Capital invested by funds: $20.4M → $14.1M (-$6.37M)
Holders
58
Holding in Top 10
1
Calls
$1.61M
Puts
$1.45M
Top Buyers
| 1 | +$2.61M | |
| 2 | +$426K | |
| 3 | +$260K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$214K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$139K |
Top Sellers
| 1 | -$1.55M | |
| 2 | -$605K | |
| 3 | -$537K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$378K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$84.4K |